NEW YORK (MainStreet) – Another day, another recall by Johnson & Johnson (Stock Quote: JNJ). The company announced Wednesday that it was recalling certain lots of its Motrin pain-relief pills, asking retailers to pull 12 million bottles off store shelves due to concerns that the pills aren’t dissolving fast enough.
The good news is that consumers aren’t being asked to pull their own Motrin out of the medicine cabinet. In its recall announcement, Johnson & Johnson stressed that “this is not a consumer-level recall, which means that consumers do not need to dispose of or return the product.” It goes on to note that the pills do not pose a risk to your health, but that pain relief may be delayed due to the medicine not dissolving quickly enough. The issue primarily affects pills approaching their expiration date.
While no one’s health seems to be in danger, it’s the latest bit of bad news for the recall-plagued company. This is the sixth recall of 2011 for Johnson & Johnson’s medical products division, McNeil Consumer Recall, which previously had to recall thousands of bottles of Tylenol due to a musty smell emanating from the pills. Those continuing issues led the Food and Drug Administration to shut down one of McNeil’s manufacturing plants back in June.
The products involved in the recall are Motrin IB tablets and caplets. While consumers don’t need to take any action, the company has nevertheless posted the lot numbers and UPC codes of the affected products on its site.
Matt Brownell is a staff reporter for MainStreet. You can reach him by email at email@example.com, or follow him on Twitter @Brownellorama.